International Journal of Clinical Psychiatry 2018, 6(1): 19-25

DOI: 10.5923/j.ijcp.20180601.03

Comparison of Sleep Quality Using Pittsburgh Sleep

Quality Index (PSQI) on Patient with Anxiety Disorders
Treated Using Long-Term and Short-Term
Benzodiazepine Therapy
Faisal Idrus1, Sonny Teddy Lisal1, Idham Jaya Ganda2, Jumiarni3,*

1
Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
2
Department of Pediatric, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
3
Postgraduate, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

Abstract Benzodiazepines are widely used and become the primary choice for sleep disorders. This study aims to
determine the comparison of sleep quality in patients with anxiety disorders using long-term and short-term benzodiazepines.
This study was a cross-sectional observational study conducted on anxiety disorder patients who undertake medical check-up
in Hasanuddin University Hospital and its network. The study was conducted from October to November 2017. The subject
of the study was 94 divided into two groups, the group of 64 subjects were taking benzodiazepine alprazolam, and the group
of 30 subjects were taking clobazam. From each group, the quality of sleep of subjects taking alprazolam and clobazam for
long-term (>6 months) and short-term (≤6 months) would be assessed. Data were analyzed statistically by using
Mann-Whitney and Wilcoxon test. The results showed that sleep quality which was measured by using an Indonesian version
of The Pittsburgh Sleep Quality Index (PSQI) to the group of subjects taking long-term alprazolam i.e >6 months (mean:
9.34±3.39) and taking short-term alprazolam i.e ≤6 month (mean: 4.06±1.07), had a very significant difference (p <0.001).
The results of the study of the groups taking long-term clobazam i.e >6 months (mean: 4.40±1.50) and those taking short-term
clobazam i.e ≤6 months (mean: 3.33±0.72) had significant differences (p= 0.021). This study concludes that sleep quality in
subjects with anxiety disorders using long-term benzodiazepine therapy either on alprazolam or clobazam was worse than
subjects who use short-term benzodiazepine therapy.
Keywords Sleep quality, Alprazolam, Clobazam, PSQI

prescribed to treat symptoms associated with sleep disorders.

1. Introduction Although in reality this drug is intended for short-term use
which is for only a few weeks but many have been using it
In 1996 the World Health Organization issued a "Rational for years. [3, 4, 6]
Use of Benzodiazepine" program because in daily practice Benzodiazepines are widely used and become the primary
benzodiazepines is not only given to patients with choice for sleep disorders, both primary and secondary sleep
psychiatric disorders, but most of these classification of disorders are sleep disturbances due to anxiety disorders and
drugs is 80% used by general practitioners and other mental disorders. However, long-term use should be
non-psychiatric physicians. Therefore, the use of limited because if used more than 6 months it may lead to
benzodiazepines is irrational and against the rules of usage some side effects such as addiction, sleep quality problems
agreed upon by the world health organization. [1, 2] or may cover the underlying diseases of sleep problems,
Benzodiazepines class of drugs known to the public as a sleep apnea, cognitive impairment and motor coordination
tranquilizer is the most popular drug in the world. disorders. Therefore, the use of benzodiazepines should be
More than 100 million benzodiazepine-class drugs have been with cautious, within medical supervision, and the dosage
use should be as low as possible. [4, 11, 12, 13]
* Corresponding author: Sleep is one important factor for basic human
[email protected] (Jumiarni)
physiological needs. A recovery process for the body and
Published online at http://journal.sapub.org/ijcp
Copyright © 2018 The Author(s). Published by Scientific & Academic Publishing brain for optimal health achievement occurs while sleeping.
This work is licensed under the Creative Commons Attribution International Sleep needs considered as the physiological needs or primary
License (CC BY). http://creativecommons.org/licenses/by/4.0/ needs that are the basic requirement for human survival and
20 Faisal Idrus et al.: Comparison of Sleep Quality Using Pittsburgh Sleep Quality Index (PSQI) on Patient
with Anxiety Disorders Treated Using Long-Term and Short-Term Benzodiazepine Therapy

this depend on the quality of sleep. Sleep quality will affect months was determined. Prior to conducting an assessment
the psychological and physical health of a person. Various of the scale of the Pittsburgh Sleep Quality Index (PSQI)
mental disorders are known to interfere with the disruption Indonesian version, firstly the validity and reliability are
of a person's sleep quality, such as anxiety disorders, tested. The data collected statistically with computerized
depression, and severe mental disorders. Sleep quality is system were processed and analyzed. Data was analyzed
measured using the Indonesian version of the Pittsburgh using statistical program (SPSS) by Mann-Whitney and
Sleep Quality Index (PSQI). The selection of the Indonesian Wilcoxon test.
version of the PSQI instrument is due to its practicality and is
easily understood. Moreover, it has been widely used in 2.3. Instrument
Indonesia with a high degree of validity and extent of The sleep quality is measured by Indonesian version of the
reliability. [5, 6, 15, 19, 20] Pittsburgh Sleep Quality Index (PSQI). This instrument has
Previous research by Holbrook et al (2000) state that the been standardized and widely used in sleep quality studies as
sleep quality on the short-time benzodiazepine use (24 weeks) in Majid research (2014). The Indonesian version of
is better than long-term use (52 weeks), but Collin et al Pittsburgh Sleep Quality Index (PSQI) Scale consists of 9
(2012), states that there is an improvement in quality of sleep questions. In this variable using the ordinal scale with the
on the use of 24 weeks to 1 year. Researchers are interested overall score of the Pittsburgh Sleep Quality Index (PSQI) is
in conducting this research due to the difference previous 0 to 21 which is derived from 7 assessment components such
research and the absence of specific research in Indonesia as subjective sleep quality, the time required to start sleep
that links the long-term use of benzodiazepines to sleep (sleep latency) sleep duration, sleep efficiency, sleep
quality. Thus, this study aims to determine the comparison of disturbance, use of medication, and sleep disturbances that
sleep quality in patients with anxiety disorders using are commonly experienced during the day (sleep duration),
long-term and short-term benzodiazepines. [13, 16, 22] sleep efficiency, daytime dysfunction. If the higher score is
obtained, the worse the quality of someone's sleep. The
advantage of this scale is having high validity and reliability.
2. Methods and Material But there are also short comings of PSQI that is in the filling
The study was an observational analytic study with cross requires assistance to reduce the difficulty of respondents
sectional design. when filling questionnaire. Each component has a score
range of 0 - 3 with 0 = never in the past month, 1 = 1 time a
2.1. Subjects week, 2 = 2 times a week and 3 = more than 3 times a week.
The subjects were recruited at the psychiatric polyclinic of The score of the seven components is summed to 1 (one)
Hasanuddin University Hospital and its networks on global score with a range of 0 - 21 values. There are two
October-November 2017. The population of this study were interpretations on this Indonesian version of PSQI is good
patients with anxiety disorder receiving benzodiazepine sleep quality if score ≤5 and sleep quality is poor if score >5.
therapy and met the inclusion criteria. All subjects were [5, 10, 21]
30-55 years old. All subjects were provided with complete
written and oral descriptions of the study, written informed
consent was also obtained. The protocol was approved by the
3. Result
local ethics committee. The characteristics of both groups were taking
benzodiazepine more than 6 months and less than 6 months.
2.2. Procedure (see table 1)
The Ethics Committee of Medical Faculty, Hasanuddin Comparison of sleep quality on 64 subjects was very
University approved the study, and all experiments significant both the groups were taking long-term alprazolam
performed in accordance with relevant guidelines and i.e >6 months the median of sleep quality is 9 whereas the
regulations. All subjects who met the inclusion criteria groups were taking alprazolam i.e ≤6 months the median of
interviewed to obtain the sample identity data including sleep quality is 4. The significance for both groups (p<0.001).
initials of name, gender, age, educational level, occupation (see table 2)
and duration therapy. In each of the benzodiazepine therapy groups of
We recorded the data of each patient who received alprazolam, indicated an increase in sleep quality scales
benzodiazepine therapy and met the inclusion criteria in the measured using the Indonesian version of the PSQI scale in
study group. Those data are their personal identity and subjects receiving therapy >6 months and ≤6 months. But
history of current and previous diseases. The scale of the there are also some subjects whose PSQI sleep quality scales
Indonesian version of the Pittsburgh Sleep Quality Index does not match the existing trend, which increases in the
(PSQI) for subjects receiving benzodiazepine therapy >6 shorter time and decreases for a longer time than other
months and those receiving benzodiazepine therapy ≤6 subjects. (see graph 1 and 2)
 International Journal of Clinical Psychiatry 2018, 6(1): 19-25 21

Table 1. Characteristic of subject

Group > 6 months Group < 6 months

(N=47) (N=47)
Variable
N % N %
Gender
Male 19 40,42 25 53,19
Female 28 59,58 22 46,81
Age (Years)
30-40 11 23,4 20 42,5
41-50 22 46,8 20 42,5
51-55 14 29,8 7 14,9
Education
Elementary School 14 29,8 3 6,4
Junior High School 6 12,8 5 10,6
Senior High School 13 27,6 20 42,5
Higher Education 14 29,8 19 40,4
Occupation
None 7 14,9 2 4,2
House wife (IRT) 19 40,4 9 19,1
Farmers 3 6,4 2 4,2
Private sector 6 12,8 18 38,3
Goverment -Profesional 7 14,9 16 34,1

Type of Benzodiazepine
Alprazolam 32 34,04 32 34,04
Clobazam 15 15,95 15 15,95

Source: Primary data, 2017

Table 2. Comparison of sleep quality scale for alprazolam

n Group >6 months Group <6 months p

Median Median
Mean+SD Mean+SD
(minimum-maximum (minimum-maximum
Long Use 64 84.00(12-204) 75.00+52.26 3.00(1-6) 3.34+1.69 <0.001
PSQI Scale 64 9.00(5-17) 9.34+3.39 4.00(3-7) 4.06+1.07 <0.001

Mann-Whitney Test, n: subject amount, DS: Deviation Standard, p : significancy

18
16
14
12
LONG USE
(YEARS) 10
PSQI SCALE 8
6
4
2
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
LONG USE (YEARS) 5 1 1 3 10 7 3 3 8 2 2 1 14 7 7 4 10 8 1 4 7 2 1 8 4 7 10 9 7 17 15 12
PSQI SCALE 7 5 7 5 10 9 6 5 7 7 6 5 13 9 13 8 11 12 11 9 11 7 7 13 10 14 15 6 9 17 9 16

Figure 1. PSQI sleep quality scale on alprazolam used >6 months

22 Faisal Idrus et al.: Comparison of Sleep Quality Using Pittsburgh Sleep Quality Index (PSQI) on Patient
with Anxiety Disorders Treated Using Long-Term and Short-Term Benzodiazepine Therapy

LONG USE 5
(MONTH) 4

3
PSQI SCALE
2

0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
LONG USE (MONTH) 3 4 3 3 6 6 4 4 2 3 6 6 4 2 3 1 1 3 6 6 3 3 4 2 2 1 3 3 1 4 1 4
PSQI SCALE 4 5 3 4 5 5 4 3 3 4 3 3 5 5 5 4 4 4 3 5 3 7 6 3 4 3 3 4 3 6 4 3

Figure 2. PSQI sleep quality scale on alprazolam used ≤6 months

Table 3. Comparison of sleep quality scale for clobazam

n Group >6 months Group <6 months p
Median Median
Mean+SD Mean+SD
(minimum-maximum (minimum-maximum
Long Use 30 36.00(12-132) 48.00+36.84 2.00(1-6) 2.33+1.49 <0.001
PSQI scale 30 4.00(3-7) 4.40+1.50 3.00(3-5) 3.33+0.72 <0.021

Mann-Whitney Test, n: subject amount, DS: Deviation Standard, p : significancy

Table 4. Comparison of sleep quality scale both of alprazolam and clobazam >6 months

n Group of Alprazolam Group of clobazam p

Median Median
Mean+DS Mean+DS
(minimum-maximum (minimum-maximum
Long Use 47 84.00(12-204) 75.00+52.26 36.00(12-32) 48.00+36.84 <0.001
PSQI Scale 47 9.00(5-17) 9.34+3.39 4.00(3-7) 4.40+1.50 0.01

Mann-Whitney Test, n: subject amount, DS: Deviation Standard, p : significancy

Table 5. Comparison of sleep quality scale both of alprazolam and clobazam ≤6 months

n Group of Alprazolam Group of clobazam p

Median Median
Mean+DS Mean+DS
(minimum-maximum (minimum-maximum
Long Use 47 3.00(1-6) 3.34+1.69 2.00(1-6) 2.33+1.49 0.51
PSQI Scale 47 4.00(3-7) 4.06+1.07 3.00(3-5) 3.33+0.72 0.09

Mann-Whitney Test, n: subject amount, DS: Deviation Standard, p : significancy

Comparison of sleep quality on 30 subjects was significant match the existing trend, such as the existing trend of
comparison both the groups were taking long-term clobazam benzodiazepine therapy groups of alprazolam, which
i.e >6 months the median of sleep quality is 4 whereas the increases in the shorter time and decreases for a longer time
groups was receiving clobazam i.e ≤6 months the median of than other subjects. (see graph 3 and 4)
sleep quality is 3. The significance for both groups (p<0.05). Comparison on 47 subjects were taking long-term both of
(see table 3) alprazolam and clobazam showed there was a significant
In each of the benzodiazepine therapy groups of clobazam, difference for sleep quality scales using the Indonesian
indicated an increase in sleep quality scales measured using version of PSQI (p<0.05) and otherwise of 47 subjects were
the Indonesian version of the PSQI scale in subjects taking short-time both of alprazolam and clobazam showed
receiving therapy >6 months and ≤6 months. But there are there was no significant difference for sleep quality scale
also some subjects whose PSQI sleep quality scales does not (p>0.05). (see table 4 and 5)
 International Journal of Clinical Psychiatry 2018, 6(1): 19-25 23

12

10

LONG USE 8
(YEARS)
PSQI SCORE 6

0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
LONG USE (YEARS) 1 1 1 11 2 3 9 4 4 2 6 6 2 1 6
PSQI SCORE 4 4 5 7 5 6 7 6 3 4 3 3 3 3 3

Figure 3. PSQI sleep quality scale on clobazam used >6 months

LONG USE 4
(MONTH)
3
PSQI SCORE
2

0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
LONG USE (MONTH) 6 3 1 2 1 2 1 3 4 1 2 1 3 4 1
PSQI SCORE 5 3 3 3 3 3 3 3 4 3 3 3 3 5 3

Figure 4. PSQI sleep quality scale on clobazam used ≤6 months

4. Discussion status and education. Although it is known most often this

anxiety disorder develops in the adult age of 25 years and
This study showed the sleep quality in anxious disorder above. [7, 8]
subjects who were taking long-term benzodiazepine therapy The results in this study were statistically tested using the
of both alprazolam and clobazam was worse than subjects Mann-Whitney and Wilcoxon test. Significant value in the
who were taking short-term therapy. groups receiving alprazolam therapy of p <0.001 was
In this study, sleep quality assessment using the obtained. The above results were also reinforced by median
Indonesian version of PSQI was performed in subjects data and mean values obtained that is; median value of sleep
receiving benzodiazepine therapy >6 months and subjects quality in groups >6 months receiving alprazolam therapy
receiving benzodiazepine therapy ≤6 months. Based on the was 9.00, the mean value was 9,34 and standard deviation
data of the subjects characteristics, the number of sexes was (SD) was 3,395. This value was higher than median value
almost equal in both groups, although statistically there were and mean in groups ≤6 months ie median=4.00, mean=4.06
more females in the >6 month group. This is in accordance and standard deviation (SD)=1.076. Similarly, in subjects
with the theory of anxiety disorders that epidemiologically receiving benzodiazepine type of clobazam therapy, there
women are twice more prone to experience anxiety disorders was a significant difference between groups >6 months and
than men. Characteristics of the subjects by age group, it is groups ≤6 months (p= 0.021) or significance p <0,05. For the
seen that the number of subjects at the age group range from value of sleep quality in groups >6 months, median value=
41 to 50 years is bigger than other age groups. Based on the 4.00, mean= 4.40 and standard deviation (SD)= 1.502 this
educational level the proportion of the distribution is almost value was higher than the value in groups ≤6 months with
the same. At the age level and education, it is mentioned that median= 3.00, mean= 3,33 and standard deviation (SD)=
anxiety disorders can occur at all age levels and all social 0.724. This result is consistent with the initial hypothesis of
24 Faisal Idrus et al.: Comparison of Sleep Quality Using Pittsburgh Sleep Quality Index (PSQI) on Patient
with Anxiety Disorders Treated Using Long-Term and Short-Term Benzodiazepine Therapy

sleep quality as measured by the Pitssburgh Sleep Quality Limitations and obstacles in this study were; no
Index (PSQI) score that sleep quality in patients receiving measurements of sleep quality scale of PSQI in subjects prior
long-term benzodiazepine therapy for >6 months is worse to therapy, no measurement of the degree scale of anxiety
than patients receiving short-term benzodiazepine therapy before the PSQI sleep scale measurement was performed,
for ≤6 months. and the participants' subjectivity in filling out the
In each of the benzodiazepine therapy groups, both questionnaire of PSQI quality of sleep.
alprazolam and clobazam, indicated an increase in sleep
quality scales measured using the Indonesian version of the
PSQI scale in subjects receiving therapy >6 months and ≤6 5. Conclusions
months. But there are also some subjects whose PSQI sleep
quality scales does not match the existing trend, which The results of this study are using the Indonesian version
increases in the shorter time and decreases for a longer time of the Pitssburgh Sleep Quality Index (PSQI), the sleep
than other subjects. This shows the varied response of each quality is worse in the subjects who take long-term
subjects to sleep quality after receiving benzodiazepine benzodiazepine use (alprazolam and clobazam) compare to
therapy. In addition, several factors such as biological factors, those who take short-term therapy. There was significantly
namely the body's response to pharmacotherapy and onset of difference sleep quality of the subjects who were taking
the disturbance experienced, psychosocial factors or long-term of both alprazolam and clobazam, otherwise there
personality of the person in overcoming stressor and was no significant difference in sleep quality of the subjects
environmental factors, mistakes or lack of understanding in who were taking short-term of both alprazolam and
filling out the questionnaire given can also make the varied clobazam. The authors recommend analyzing the sleep
response. As is known, many factors might affect one’s quality of long-term use of other benzodiazepine derivatives
quality of sleep, among others, health status, environment, such as lorazepam, estazolam, diazepam compared
psychological stress, diet, drugs, lifestyle. [15, 18] nonbenzodiazepine groups such as zolpidem, zaleplon, and
The difference in sleep quality results in alprazolam and ramelteon.
clobazam may also be due to differences in chemical
structure between the two. Alprazolam has a chemical ACKNOWLEDGEMENTS
structure of 8-chloro-1-methyl-6-phenyl-4H-triazole [4,3-α]
-benzodiazepine and the formula (C17H13CIN4) while The authors declare no potential conflict of interest in
clobazam has a chemical structure of writing this original article. The authors would like to
7-chloro-1-methyl-5-phenyl-1,5 benzodiazepine-2,4 (3H, acknowledge the important support and contributions of
5H) -dione and C16H13CIN2O2 formulas. Clobazam is the Irfan Idris, M.D. (department of physiology) and Idham Jaya
newest derivative of the benzodiazepine group used ganda, M.D. (Pediatrician; Research Methodology Advisor).
primarily for anxiolytic and more specific anti-convulsions
having substituted 1.5 diazepine instead of the usual
substitution of 1.4 diazepine, and has the least sedation effect
compared to other benzodiazepines. [9, 14, 17, 23] REFERENCES
Before conducting an assessment of the scale of the
Pittsburgh Sleep Quality Index (PSQI) Indonesian version, [1] Andri. What is psychosomatic and How?. Medic Publishing.
then first tested was the validity and reliability. Validity Jakarta. 2011.
test aims to measure the quality of research instruments. The [2] Hawari, D. Management of Stress, Anxiety and Depression.
instrument is said to be valid if the instrument can measure Medical Faculty of Indonesia University. Jakarta. 2013.
what should be measured. A research instrument is
[3] Stahl, S.M. Disorder of Sleep and Wakefulness and Their
acceptable if the loading value of each item is ≥0.4. PSQI Treatment. Stahl’l Essential Psychopharmacology-Neuroscie
questionnaire in this study obtained loading of each item is tific Basis and practical Applications. Third Edition.
≥0,6, so the scale of Pitssburgh Sleep Quality Index (PSQI) Cambridge University Press. 2008: 732-741.
Indonesian version used is valid. [5, 10]
[4] Amir, N. Diagnose and Therapy of Sleep Disorder for older.
Reliability test aims to measure the reliability of a Medical Faculty of Indonesia University Jakarta. 196-206.
measuring instrument or questionnaire. The instrument is 2007.
said to be reliable if used multiple times to measure the same
object will produce the same data, a research instrument can [5] Curcio G., Tempesta D., Scarlanta S., Marzano C., Moroni F.,
Rossini P., et al. validity of the Pittsburgh Sleep Quality Index
be said to be reliable if it has a Cronbach’s Alpha value of (PSQI) Neuronal Sci. Pubmed US National Library of
≥0.60. The closer to the number 1 cronbach’s alpha value, Medicine. 2012.
the better the instrument is. In this study, reliability testing
was using Cronbach’s alpha analysis method with the help of [6] Lumbantobing, S.M. Sleep Disorder. Medical Faculty of
Indonesia University. Jakarta. 2008.
SPSS, and was obtained Cronbach’s alpha of 0.810 so that
the scale of Indonesian version of PSQI used in this research [7] Kaplan, H., Sadock, B., Grebb, J., Anxiety Disorder in
can be said reliable. [5, 10] Synopsis of Psychiatri, Binarupa Aksara. Jakarta. 17-76.
 International Journal of Clinical Psychiatry 2018, 6(1): 19-25 25

2010. [16] Holbrook, A.M., et.al., Meta-Analysis of Benzodiazepine Use

in The Treatment of Insomnia. Review article. 2000: 162(2):
[8] Chen, L., Bell, S. et al. The Association Between 225-33.
Benzodiazepine Use and Sleep Quality in Residential Aged
Care Facilities: a Cross Sectional Study. Research article. [17] Kaplan, H., Sadock, B., Benzodiazepine and Drugs Acting on
BMC Geriatrics. 16:196. 2016. Benzodiazepine Receptors. Pocket Handbook of Psychiatric
Drug Treatment, 4thed. Lippincott Williams & Wilkins. New
[9] Castillo, A; Sotillo, C; Mariategui, J. Alprazolam Compared York. 2006: 72-81.
to Clobazam and Placebo in Anxious Outpatients. Instituto
Nacional de salud Mental, Honorio Delgado-Lima, Peru. [18] Kramer M., Ruth M., Long Term Use of Hypnotic Agents in
2008. The Treatment Insomnia. (online) http://ps.psychiatryonline.
org/vol.56/no.62011.
[10] Contreras F.H., Lopez E.M., Roman P.A.L., Garrido F.,
Santos M.A., Amat A.M. Reliability and validity of the [19] Lu, J., Greco, M.A., Sleep Circuit and The Hypnotic
Pittsburgh Sleep Quality Index (PSQI). Int.34 929-936. 2014. Mechanisme of GABA-A Drugs. Journal of Clinical Sleep
Medicine Vol.2. No.2. Menlo Park. CA. 2006.
[11] Ancoli, S. 2010. Sleep Disorders in Older Adults a Mini
Review. USA: Gerontology; 56:181–189. [20] Rickels, K. et.al., Effect of Long-Term Benzodiazepine use,
British Journal Clinical Pharmacology. 2008:107–113.
[12] Arana, G.W., Rosenbaum, J.F. Benzodiazepine, Handbook of
Psychiatry Drug Teraphy, 4th ed. Baltimore, Lippincott [21] Vicens, C., Benloucif, S. et.al., Morning or Evening Activity
Williams & Wilkins, USA, 2000: 170-52. Improves Neuropsychological Performance and Subjective
Sleep Quality in Older Adults Sleep. The British Journal of
[13] Bastien, C.H., Le Blanc, M., Carrier, J. Sleep EEG Power Psychiatry. 2014.
Spectra, Insomnia, and Chronic Use of Benzodiazepines.
Canada. 2003. [22] Vinkers, C.H., and Olivier, B., Mechanisme Underlying
Tolerance after long-term Benzodiazepine Use: A Future
[14] Pharmacology Department Medical Faculty of Indonesia Subtype-Selective GABAA Receptors Modulators?. Review
University, Benzodiazepin in Pharmacology and Therapy, Article. 2011.
Medical Faculty of Indonesia University. 5-edition, Jakarta.
2010. [23] Wildin, JD; Pleuvry, BJ. Mawer, GE; Millington, L.,
Respiratory and Sedative effects of Clobazam and
[15] Guyton, A.C., Hall, J.E., Textbook of Medical Phisiology. Clonazepam in Volunteers. British Journal of Clinical
Mississipi: Saunder –Elsevier. 2014: 779-782. Pharmacology. 2009.